(Q82532886)
Statements
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation (English)
Federica Sorà
Patrizia Chiusolo
Elisabetta Metafuni
Silvia Bellesi
Luca Laurenti
Giuseppe Ausoni
Gina Zini
Alina J Bayer
Balducci Mario
18 November 2010